Atlas Trials

Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance

Clinical trial NCT02156271 · COMPLETED

Trial details

NCT number
NCT02156271
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Insomnia
Start date
2007-07-01
Primary completion
2008-06-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.